Danit Sofer

1.7k total citations
51 papers, 1.0k citations indexed

About

Danit Sofer is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Danit Sofer has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 33 papers in Cardiology and Cardiovascular Medicine and 13 papers in Epidemiology. Recurrent topics in Danit Sofer's work include Viral Infections and Immunology Research (33 papers), Viral gastroenteritis research and epidemiology (30 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Danit Sofer is often cited by papers focused on Viral Infections and Immunology Research (33 papers), Viral gastroenteritis research and epidemiology (30 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Danit Sofer collaborates with scholars based in Israel, United States and Switzerland. Danit Sofer's co-authors include Ella Mendelson, Lester M. Shulman, Musa Hindiyeh, Y. Manor, Jacob Moran‐Gilad, Yaniv Lustig, Itamar Grotto, Efrat Bucris, Ronni Gamzu and Merav Weil and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Applied and Environmental Microbiology.

In The Last Decade

Danit Sofer

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danit Sofer Israel 17 800 483 201 167 150 51 1.0k
Jagadish M. Deshpande India 20 1.6k 2.0× 1.3k 2.6× 319 1.6× 316 1.9× 93 0.6× 54 1.9k
Carita Savolainen‐Kopra Finland 20 833 1.0× 598 1.2× 603 3.0× 131 0.8× 30 0.2× 53 1.4k
Tsuguto Fujimoto Japan 23 811 1.0× 579 1.2× 575 2.9× 261 1.6× 56 0.4× 93 1.5k
Phan Văn Tú Vietnam 9 549 0.7× 483 1.0× 386 1.9× 410 2.5× 25 0.2× 12 933
Ananda S Bandyopadhyay United States 22 1.2k 1.5× 1.1k 2.4× 392 2.0× 146 0.9× 50 0.3× 73 1.5k
Salmaan Sharif Pakistan 20 1.2k 1.5× 718 1.5× 601 3.0× 138 0.8× 129 0.9× 65 1.6k
Suresh B. Selvaraju United States 15 394 0.5× 202 0.4× 456 2.3× 63 0.4× 84 0.6× 26 849
Linda L. Han United States 9 928 1.2× 444 0.9× 408 2.0× 188 1.1× 245 1.6× 14 1.4k
Daryl M. Lamson United States 15 569 0.7× 309 0.6× 783 3.9× 69 0.4× 41 0.3× 38 1.2k
Harrie van der Avoort Netherlands 15 1.4k 1.8× 1.2k 2.4× 355 1.8× 275 1.6× 44 0.3× 17 1.7k

Countries citing papers authored by Danit Sofer

Since Specialization
Citations

This map shows the geographic impact of Danit Sofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danit Sofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danit Sofer more than expected).

Fields of papers citing papers by Danit Sofer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danit Sofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danit Sofer. The network helps show where Danit Sofer may publish in the future.

Co-authorship network of co-authors of Danit Sofer

This figure shows the co-authorship network connecting the top 25 collaborators of Danit Sofer. A scholar is included among the top collaborators of Danit Sofer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danit Sofer. Danit Sofer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erster, Oran, Itay Bar-Or, Roberto Azar, et al.. (2024). Incursion of SARS-CoV-2 BA.2.86.1 variant into Israel: National-scale wastewater surveillance using a novel quantitative real-time PCR assay. The Science of The Total Environment. 933. 173164–173164.
2.
Kriger, Or, Oran Erster, Neta S. Zuckerman, et al.. (2024). Molecular Analysis of Coxsackievirus B2 Associated With Severe Symptoms of the Central Nervous System. Journal of Medical Virology. 96(11). e70066–e70066.
3.
Zuckerman, Neta S., Efrat Bucris, Oran Erster, et al.. (2024). Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023: a genomic epidemiology study. The Lancet Microbe. 5(10). 100893–100893. 5 indexed citations
4.
Weil, Merav, Danit Sofer, Lester M. Shulman, et al.. (2023). Environmental surveillance detected type 3 vaccine-derived polioviruses in increasing frequency at multiple sites prior to detection of a poliomyelitis case. The Science of The Total Environment. 871. 161985–161985. 11 indexed citations
5.
Kriger, Or, et al.. (2023). Increased detection of Echovirus 6-associated meningitis in patients hospitalized during the COVID-19 pandemic, Israel 2021–2022. Journal of Clinical Virology. 162. 105425–105425. 8 indexed citations
6.
Sofer, Danit, Merav Weil, Tamy Shohat, et al.. (2023). Oral and fecal polio vaccine excretion following bOPV vaccination among Israeli infants. Vaccine. 41(28). 4144–4150. 1 indexed citations
7.
Zuckerman, Neta S., Efrat Bucris, Yaron Drori, et al.. (2021). Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel. PLoS ONE. 16(3). e0243265–e0243265. 3 indexed citations
8.
Shulman, Lester M., Merav Weil, Raz Somech, et al.. (2020). Underperformed and Underreported Testing for Persistent Oropharyngeal Poliovirus Infections in Primary Immune Deficient Patients—Risk for Reemergence of Polioviruses. Journal of the Pediatric Infectious Diseases Society. 10(3). 326–333.
9.
Weil, Merav, Galia Rahav, Tali Stauber, et al.. (2019). First report of a persistent oropharyngeal infection of type 2 vaccine-derived poliovirus (iVDPV2) in a primary immune deficient (PID) patient after eradication of wild type 2 poliovirus. International Journal of Infectious Diseases. 83. 40–43. 5 indexed citations
10.
Laassri, Majid, Sharon Hassin‐Baer, Rachel Handsher, et al.. (2018). Evolution of echovirus 11 in a chronically infected immunodeficient patient. PLoS Pathogens. 14(3). e1006943–e1006943. 7 indexed citations
11.
Weil, Merav, Michal Mandelboim, Ella Mendelson, et al.. (2016). Human enterovirus D68 in clinical and sewage samples in Israel. Journal of Clinical Virology. 86. 52–55. 12 indexed citations
12.
Shulman, Lester M., Yossi Manor, Musa Hindiyeh, Danit Sofer, & Ella Mendelson. (2016). Molecular Characterization of Polio from Environmental Samples: ISSP, The Israeli Sewage Surveillance Protocol. Methods in molecular biology. 1387. 55–107. 9 indexed citations
13.
Moran‐Gilad, Jacob, Ella Mendelson, Cara C. Burns, et al.. (2015). Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel. Journal of Clinical Virology. 66. 51–55. 10 indexed citations
14.
Tasher, Diana, Galia Rahav, Hagai Levine, et al.. (2015). How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience. Vaccine. 34(3). 299–301. 4 indexed citations
15.
Ben‐Chetrit, Eli, Yonit Wiener‐Well, Lester M. Shulman, et al.. (2014). Coxsackievirus A6-related hand foot and mouth disease: Skin manifestations in a cluster of adult patients. Journal of Clinical Virology. 59(3). 201–203. 37 indexed citations
16.
Weil, Merav, Tamar Shohat, Michal Bromberg, et al.. (2012). The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel. Influenza and Other Respiratory Viruses. 7(5). 838–846. 10 indexed citations
17.
Shulman, Lester M., Danit Sofer, Yossi Manor, et al.. (2011). Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates. PLoS ONE. 6(5). e18360–e18360. 10 indexed citations
18.
Shulman, Lester M., Yossi Manor, Danit Sofer, et al.. (2006). Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations. PLoS ONE. 1(1). e69–e69. 49 indexed citations
19.
Calderon‐Margalit, Ronit, Danit Sofer, Martin Lewis, et al.. (2004). Immune status to poliovirus among immigrant workers in Israel. Preventive Medicine. 40(6). 685–689. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jagadish M. Deshpande Breakdown of academic impact, for papers by Carita Savolainen‐Kopra Breakdown of academic impact, for papers by Tsuguto Fujimoto Breakdown of academic impact, for papers by Phan Văn Tú Breakdown of academic impact, for papers by Ananda S Bandyopadhyay Breakdown of academic impact, for papers by Salmaan Sharif Breakdown of academic impact, for papers by Suresh B. Selvaraju Breakdown of academic impact, for papers by Linda L. Han Breakdown of academic impact, for papers by Daryl M. Lamson Breakdown of academic impact, for papers by Harrie van der Avoort
Rankless by CCL
2026